STATEMENT OF CONSOLIDATED CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Oct. 31, 2016	Oct. 31, 2015	Oct. 31, 2014
Cash Flows from Operating Activities
Net income	$ 1,521.5	$ 1,940.9	$ 3,163.3
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	94.3	55.4	38.1
Provision for depreciation and amortization	1,559.8	1,382.4	1,306.5
Impairment charges	85.1	34.8	95.9
Share-based compensation expense	70.6	66.1	78.5
Undistributed earnings of unconsolidated affiliates	(1.9)	(1.0)	9.3
Provision (credit) for deferred income taxes	282.7	(18.4)	(280.1)
Changes in assets and liabilities:
Trade, notes and financing receivables related to sales	335.2	811.6	(749.0)
Insurance receivables		333.4	(149.9)
Inventories	(106.1)	(691.4)	(297.9)
Accounts payable and accrued expenses	(155.2)	(503.6)	(137.1)
Accrued income taxes payable/receivable	1.6	(137.6)	342.6
Retirement benefits	238.6	427.5	336.9
Other	(161.9)	40.2	(231.2)
Net cash provided by operating activities	3,764.3	3,740.3	3,525.9
Cash Flows from Investing Activities
Collections of receivables (excluding receivables related to sales)	14,611.4	14,919.7	15,319.1
Proceeds from maturities and sales of marketable securities	169.4	860.7	1,022.5
Proceeds from sales of equipment on operating leases	1,256.2	1,049.4	1,091.5
Proceeds from sales of businesses and unconsolidated affiliates, net of cash sold	81.1	149.2	345.8
Cost of receivables acquired (excluding receivables related to sales)	(13,954.5)	(14,996.5)	(17,240.4)
Purchases of marketable securities	(171.2)	(154.9)	(614.6)
Purchases of property and equipment	(644.4)	(694.0)	(1,048.3)
Cost of equipment on operating leases acquired	(2,310.7)	(2,132.1)	(1,611.0)
Acquisitions of businesses, net of cash acquired	(198.5)
Other	(16.0)	(60.2)	(145.6)
Net cash used for investing activities	(1,177.2)	(1,058.7)	(2,881.0)
Cash Flows from Financing Activities
Increase (decrease) in total short-term borrowings	(1,213.6)	501.6	89.2
Proceeds from long-term borrowings	5,070.7	5,711.0	8,232.0
Payments of long-term borrowings	(5,267.6)	(4,863.2)	(5,209.1)
Proceeds from issuance of common stock	36.0	172.1	149.5
Repurchases of common stock	(205.4)	(2,770.7)	(2,731.1)
Dividends paid	(761.3)	(816.3)	(786.0)
Excess tax benefits from share-based compensation	5.4	18.5	30.8
Other	(64.7)	(72.1)	(63.6)
Net cash used for financing activities	(2,400.5)	(2,119.1)	(288.3)
Effect of Exchange Rate Changes on Cash and Cash Equivalents	(13.0)	(187.3)	(73.6)
Net Increase in Cash and Cash Equivalents	173.6	375.2	283.0
Cash and Cash Equivalents at Beginning of Year	4,162.2	3,787.0	3,504.0
Cash and Cash Equivalents at End of Year	$ 4,335.8	$ 4,162.2	$ 3,787.0